Pathologic complete response to neoadjuvant imatinib of a gastric stromal tumor with concomitant mutations in
KIT
PDGFRA
imatinib
mutation
pathologic complete response
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
25
12
2022
revised:
03
05
2023
accepted:
23
05
2023
medline:
12
6
2023
pubmed:
12
6
2023
entrez:
12
6
2023
Statut:
epublish
Résumé
We report the first case of pathologic complete response (pCR) to neoadjuvant imatinib in a gastric stromal tumor harboring pCR of GIST to neoadjuvant imatinib is rare. We report a case of pCR to neoadjuvant imatinib in a gastric stromal tumor that harbored co-occurrence of multiple
Identifiants
pubmed: 37305871
doi: 10.1002/ccr3.7463
pii: CCR37463
pmc: PMC10248213
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e7463Informations de copyright
© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
The authors have no conflict of interest to declare.
Références
Anticancer Res. 2010 Jun;30(6):2407-14
pubmed: 20651400
Mod Pathol. 2019 Jul;32(7):957-966
pubmed: 30760858
Eur J Surg Oncol. 2022 Aug;48(8):1739-1745
pubmed: 35033400
Ann Surg Oncol. 2006 Dec;13(12):1596-603
pubmed: 16957966
Int J Cancer. 2011 Mar 15;128(6):1251-8
pubmed: 20957633
Lung Cancer. 2008 Dec;62(3):316-20
pubmed: 18448188
Turk J Haematol. 2012 Mar;29(1):10-6
pubmed: 24744618
Anticancer Drugs. 2008 Jul;19(6):607-12
pubmed: 18525320
Trends Cancer. 2018 Jan;4(1):74-91
pubmed: 29413424
Ther Adv Med Oncol. 2012 Sep;4(5):255-70
pubmed: 22942908
Clin Cancer Res. 2005 Jun 1;11(11):4182-90
pubmed: 15930355
Anticancer Res. 2014 Feb;34(2):905-7
pubmed: 24511030
Front Oncol. 2020 Apr 22;10:504
pubmed: 32391261
Anticancer Res. 2014 Nov;34(11):6617-25
pubmed: 25368266
Eur J Gastroenterol Hepatol. 2007 Aug;19(8):711-3
pubmed: 17625442
J Clin Oncol. 2005 Mar 1;23(7):1580-2
pubmed: 15735135
Genes Chromosomes Cancer. 2008 Oct;47(10):853-9
pubmed: 18615679
Cancers (Basel). 2021 Feb 27;13(5):
pubmed: 33673554
Am J Surg. 2003 Dec;186(6):665-9
pubmed: 14672776
J Mol Biol. 2007 Oct 12;373(1):211-8
pubmed: 17765922
J Natl Compr Canc Netw. 2018 Dec;16(12):1424-1428
pubmed: 30545989
Gut. 2006 Apr;55(4):585-6
pubmed: 16531543
Ann Surg Oncol. 2013 Sep;20(9):2937-43
pubmed: 23760587
J Clin Oncol. 2007 May 1;25(13):1753-9
pubmed: 17470865
J Med Case Rep. 2011 May 21;5:197
pubmed: 21600007
PLoS One. 2020 Mar 4;15(3):e0229712
pubmed: 32130260
Ann Surg Oncol. 2007 Jan;14(1):14-24
pubmed: 17072676
Int J Surg Case Rep. 2014;5(10):681-5
pubmed: 25194604
Colorectal Dis. 2011 Oct;13(10):1110-5
pubmed: 21040362
Int J Cancer. 2005 Nov 1;117(2):316-25
pubmed: 15900603
World J Gastroenterol. 2009 Apr 21;15(15):1910-3
pubmed: 19370794
Histopathology. 2008 Sep;53(3):245-66
pubmed: 18312355
Mol Cell Biol. 2003 May;23(9):3067-78
pubmed: 12697809
ESMO Open. 2018 Apr 06;3(3):e000335
pubmed: 29636989
Nat Rev Cancer. 2011 Nov 17;11(12):865-78
pubmed: 22089421
Int J Clin Oncol. 2011 Jun;16(3):279-83
pubmed: 20922448
World J Gastroenterol. 2008 Jun 21;14(23):3763-7
pubmed: 18595147
Intern Med. 2005 Nov;44(11):1163-8
pubmed: 16357454
Purinergic Signal. 2010 Sep;6(3):327-37
pubmed: 21103216